Certified defibrillator pads as overdose harm reduction

The FY2026 report lists one program, EMS support, at 2,478.00 funded and spent, recipient EMS (pp4 to 6). It gives the primary problem as opioid and the purpose as opioid overdose response. It files the program under Harm Reduction and Overdose Prevention, with the Schedule B strategy Training, and reports 0 individuals served. It gives the funding date as 01/07/2026 and the launch date as 09/01/2026. The report names the purchase only in its administrative details, 30 powerheart G5 defibulator pads purchased, while it certifies 0.00 of administrative spending (p2). The account's one payment in the year is purchase order 25-02282 to Team Life, Inc., 30 Powerheart G5 defibrillator pads, 2,478.00, encumbered 06/20/2025 and paid by check 39218 on 07/21/2025. The payment came before both reported dates. No training was bought. The Township bought the same pads from its Current Fund in 2023 and 2024. Defibrillator pads treat cardiac arrest. No overdose program using them is documented, and they are not among the uses Exhibit E lists.